Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, February 13, 2020
[ Thu, Feb 13th 2020
] - WOPRAI
[ Thu, Feb 13th 2020
] - WOPRAI
Wed, February 12, 2020
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
[ Wed, Feb 12th 2020
] - WOPRAI
Sel Hardy Maintained (TEVA) at Hold with Increased Target to $13 on, Feb 12th, 2020
Sel Hardy of CFRA, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Increased Target from $11 to $13 on, Feb 12th, 2020.
Sel has made no other calls on TEVA in the last 4 months.
There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, all agree with Sel's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jacob Hughes of "Wells Fargo" Maintained at Hold with Increased Target to $10 on, Wednesday, January 22nd, 2020
- Chris Schott of "JP Morgan" Upgraded from Sell to Hold on, Tuesday, November 12th, 2019
- David Amsellem of "Piper Sandler" Maintained at Hold with Increased Target to $7 on, Friday, November 8th, 2019
